Shared on 01 Nov 25
Narrative Update on Astral: Analyst Price Target Revision Analysts have maintained their fair value estimate for Astral at ₹1,553.08, citing consistency in key company fundamentals and minimal adjustment in projections. What's in the News The board meeting is scheduled for November 5, 2025, to review unaudited financial results for the second quarter and half-year ended September 30, 2025 (Key Developments).
Shared on 17 Oct 25
Fair value Increased 0.91%Analysts have raised their price target for Astral from ₹1,539.08 to ₹1,553.08, citing modest improvements in profit margin projections and future valuation multiples. What's in the News The Board of Directors of Astral Limited will meet on August 11, 2025, at 14:30 Indian Standard Time to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2025 (Board Meeting).
Shared on 03 Oct 25
Fair value Increased 2.24%Analysts have raised their price target for Astral from ₹1,505.41 to ₹1,539.08, citing expectations of improved revenue growth and profit margins. What's in the News Astral Limited has scheduled a Board Meeting on August 11, 2025, at 14:30 IST to review and approve the unaudited standalone and consolidated financial results for the quarter ending June 30, 2025.
Shared on 05 Sep 25
Fair value Decreased 0.47%With both Astral’s Future P/E and consensus revenue growth forecasts remaining virtually unchanged, analysts have made only a minor downward revision to the fair value price target from ₹1513 to ₹1505. What's in the News Astral's board will meet to review and approve unaudited standalone and consolidated financial results for the quarter ended 30 June, 2025.
Shared on 23 Apr 25
Fair value Decreased 1.65%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 17 Apr 25
Fair value Decreased 1.27%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 09 Apr 25
Fair value Decreased 0.79%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 02 Apr 25
Fair value Increased 0.26%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 26 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 19 Mar 25
Fair value Increased 11%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 12 Mar 25
Fair value Decreased 29%AnalystConsensusTarget has decreased revenue growth from 18.4% to 15.3%, decreased profit margin from 11.4% to 10.2%, decreased future PE multiple from 83.1x to 72.7x and increased shares outstanding growth rate from -0.0% to 0.0%.